Faecalibacterium prausnitzii.

Inulin is fermented in the colon to acetate and lactate, the cross-feeding substrates this butyrate producer uses. Supplying the fibre alongside the organism gives it something to grow on rather than relying on background diet.

PHGG ferments slowly along the whole colon and raises butyrate output. That fermentation profile matches where this organism sits and feeds it directly.

Pectin is degraded by primary fermenters into acetate and oligosaccharides. F. prausnitzii takes up that acetate and converts it to butyrate.

Bifidobacteria release acetate and lactate as they ferment oligosaccharides. F. prausnitzii consumes both and turns them into butyrate, the classic cross-feeding chain.

B. lactis acidifies the lumen and supplies acetate. That acetate is the carbon source this butyrate producer draws on.

Akkermansia degrades mucin and releases oligosaccharides and acetate into the mucus layer. Those released sugars are usable by butyrate producers living in the same niche.

Oat beta-glucan is fermented to short-chain fatty acids with a notable butyrate share. It gives the strain fermentable material that survives to the distal colon.

Berberine has broad antibacterial activity in the gut lumen and shifts community composition. Taken in the same dose window it can work against a live commensal you are trying to establish, so spacing them apart is the sensible formulation call.

Carvacrol and thymol disrupt bacterial membranes broadly rather than selectively. Delivered together with a live commensal they reduce the number of viable organisms arriving in the colon.

Charcoal adsorbs small organic molecules indiscriminately in the gut lumen, including fermentation products. Co-dosing is therefore worth avoiding, so the two belong at different times of day.

Resistant starch escapes small-intestinal digestion and arrives in the colon as fermentable substrate. Faecalibacterium prausnitzii is a butyrate producer that grows on the acetate and simple sugars released when primary degraders break that starch down. Supplying substrate is the usual way this organism is supported in the gut. The pairing is a substrate relationship, not a measured clinical outcome.

Galactooligosaccharides are fermented mainly by bifidobacteria, which release acetate and lactate. Faecalibacterium prausnitzii consumes acetate and converts it to butyrate, so cross-feeding is the route by which a bifidogenic fibre can raise butyrate output. The step is well described in fermentation studies of mixed cultures.

Short-chain fructans reach the proximal colon largely intact and are fermented rapidly. The acetate produced feeds acetate-to-butyrate converters including Faecalibacterium prausnitzii. Rapid fermentation also produces gas, which is why tolerance varies between people.

Psyllium is only partially fermented, so it holds water and slows transit while still delivering some substrate to the colonic community. That combination of a gel-forming and a partly fermentable fibre gives butyrate producers a slower, steadier supply than a rapidly fermented oligosaccharide. The claim here is about substrate delivery, not about any measured change in a person.

Butyrate is the end product Faecalibacterium prausnitzii makes from acetate and fermentable carbohydrate, and it is the preferred energy substrate of colonocytes. Supplying butyrate directly delivers the same molecule without requiring the fermentation step. The two approaches converge on the same metabolite, which is why they are usually considered together rather than in isolation.

Lactate from lactobacilli is taken up by lactate-utilising butyrate producers in the colon. Faecalibacterium prausnitzii is among the organisms that benefit from that hand-off in mixed culture. The relationship is described at the level of microbial metabolism, not as a clinical result.

Chicory-derived inulin is a long-chain fructan fermented across the length of the colon. In laying hens, inulin feeding was linked to Faecalibacterium-derived spermidine and to lower liver fat measures, an animal finding rather than human evidence. The substrate relationship itself is standard fermentation biochemistry.

Faecalibacterium can produce spermidine, a polyamine involved in intestinal epithelial renewal. In laying hens given inulin, Faecalibacterium-derived spermidine was reported as the mediating step for lower liver fat measures. This is animal data and a mechanistic marker, not a demonstrated human outcome.

Glutamine is the main fuel of small-intestinal enterocytes, while butyrate from Faecalibacterium prausnitzii fuels colonocytes. The two feed different segments of the same lining rather than competing for one pathway. Nothing here shows a combined effect in people. It is a division of substrate along the gut.

Vitamin D receptor signalling in intestinal epithelium influences tight-junction protein expression and mucosal immune tone, the same barrier machinery butyrate acts on. The overlap is at the level of epithelial signalling and is described mechanistically. No combination trial supports a joint effect.

In a randomised supplementation trial, magnesium was associated with shifts in gut microbiome composition and in bacterial vitamin D metabolism. The report concerns microbial community measures, which are markers rather than clinical outcomes. Whether Faecalibacterium prausnitzii specifically benefits is not settled by that work.

Most catechins pass unabsorbed into the colon, where the resident community cleaves them into smaller phenolics. Those transformations change the local environment butyrate producers grow in, and polyphenol feeding is a recognised way to shift community composition. Direction and size of any effect on Faecalibacterium prausnitzii vary between reports.

Quercetin glycosides are poorly absorbed and reach the colon, where bacterial enzymes deglycosylate and degrade them. The resulting phenolic acids alter the growth environment for anaerobes including butyrate producers. This is a community-level modulation, described in fermentation and animal work rather than clinical trials.

Saccharomyces boulardii is a yeast that transits the gut without colonising and is used to keep the resident community from being crowded out during disruption. Faecalibacterium prausnitzii is one of the organisms that falls when the anaerobic community is disturbed. The pairing rests on ecology rather than on a study of the two together.

Cereal beta-glucan is viscous in the small intestine and fermentable in the colon, producing short-chain fatty acids including butyrate. The fermentation depends on a community with intact butyrate producers. Reported shifts are in microbial and metabolite measures, not clinical endpoints.